Shilpa Gupta - Concepedia

Author

Shilpa Gupta

University of Minnesota Medical Center ORCID

Also Known As

S. Gupta, Shilpa Gupta

Publications

743

Citations

H-Index

Concepts

All Affiliations

University of Minnesota Medical Center Huntsman Cancer Institute Cleveland Clinic University of North Carolina at Chapel Hill Johns Hopkins University

About

Shilpa Gupta is an author at University of Minnesota Medical Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	268
2	Public Health	1	1	18
3	Epidemiology	1	1	18
4	Immunology	1	1	39
5	Pathology	1	1	134

Shilpa Gupta

Publications

431

Citations

H-Index

Page 1

	Year	Citations
Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy. Shilpa Gupta, Guru Sonpavde, Christopher Weight, Journal of Clinical Oncology Radical CystectomySurgical OncologyUrologyPd-l1 ExpressionGenitourinary Cancer	2020	134
Significance of Incidental Desmoids Identified During Surgery for Familial Adenomatous Polyposis John E. Hartley, James M. Church, Shilpa Gupta, Diseases of the Colon & Rectum	2004	97
EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma Christopher Hoimes, Jonathan E. Rosenberg, S. Srinivas, Annals of Oncology UrologyMetastatic Urothelial CarcinomaInitial ResultsGenitourinary CancerMedicine	2019	52
A phase II randomized, double-blind study of sipuleucel-T followed by IDO pathway inhibitor, indoximod, or placebo in the treatment of patients with metastatic castration resistant prostate cancer (mCRPC). Gautam Jha, Shilpa Gupta, Scott T. Tagawa, Journal of Clinical Oncology Indoximod ArmImmunologyImmune RegulationImmunoeditingPharmacotherapy	2017	39
Randomized double-blind phase II study of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients (pts) with metastatic urothelial cancer (mUC): HCRN GU14-182. Matt D. Galsky, Sumanta K. Pal, Amir Mortazavi, Journal of Clinical Oncology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineMaintenance Pembro	2019	25
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial Thomas Powles, Michiel S. van der Heijden, Y. Loriot, Annals of Oncology	2025	23
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19). Jeremy L. Warner, Sam Rubinstein, Petros Grivas, Journal of Clinical Oncology Lba110 BackgroundCancer ManagementEpidemiology Of CancerPrognosisCovid-19 Epidemiology	2020	18
Pott's puffy tumor: Sonographic diagnosis Brighita Weinberg, Shilpa Gupta, Manuel J. Thomas, Journal of Clinical Ultrasound	2005	17
Solitary intrascrotal neurofibroma: A case diagnosed on aspiration cytology Shilpa Gupta, Ruchika Gupta, Sompal Singh, Diagnostic Cytopathology	2010	15
Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population Anna S Jan, Dawn Dolan, Kris Lombardi, Clinical Genitourinary Cancer	2015	11

Page 1